Mounjaro stock: when it's back and how to get it through a legal UK route

The decision you're actually facing right now

If you've searched this question, you're probably already taking Mounjaro (or you were trying to start) and you've hit a wall. Shortage notices, back-order messages, unclear timelines. It's genuinely frustrating, especially when you've seen progress and don't want to lose momentum. The first thing worth knowing is that the shortage is intermittent rather than absolute. Eli Lilly has been scaling UK supply, and most doses have been available at various points in 2025 and 2026, though not always at every provider simultaneously.

The practical decision in front of you is this: do you wait, switch, or find a regulated pharmacy with confirmed stock? Each option has trade-offs, and that's a conversation worth having with your prescriber rather than settling on your own. What we can do here is explain what a safe and legal route to Mounjaro looks like, so you can make that call with clear information. If you're trying to plan ahead, our page on when Mounjaro is likely to be back in stock covers what the current supply picture looks like and what to expect. If you'd like to see what's currently available, checking live stock status at a regulated pharmacy is the quickest first step.

Why the only legal route matters more when supply is tight

Pressure on legitimate supply has a predictable side-effect: sellers appear in the gaps. The MHRA has warned repeatedly about counterfeit and illegally traded weight-loss pens circulating online and via social media. In October 2025, enforcement teams raided the first illicit UK manufacturing site producing fake tirzepatide pens, roughly 20 million doses of illegally traded weight-loss medicines, worth around £45 million, were seized across 2025 enforcement operations. Some counterfeit pens have contained insulin instead of the stated medicine, with serious consequences for patients. The MHRA's advice is clear: report any seller offering a Prescription-Only Medicine without requiring a prescription to the Yellow Card scheme. Red flags include social-media sellers, prices that seem implausibly low, and any listing that skips clinical assessment entirely.

Verifying a pharmacy takes about thirty seconds. Search the GPhC pharmacy register for the name or registration number; if it isn't listed, do not buy from it. This check is the single most useful thing you can do before handing over payment details anywhere. If you want to verify us specifically, our premises registration is 9012878 on that register.

How the process works at a regulated pharmacy, and what to expect if stock is low

At a legitimate online pharmacy, the route to Mounjaro runs through a clinical consultation every single time. At nume, that means completing a free medical questionnaire, then photo-ID verification and live weight confirmation on video. A GPhC-registered Independent Prescriber reads your answers personally and, if Mounjaro is clinically appropriate, issues a prescription. If you're an existing patient requesting a repeat or a dose increase, we ask for evidence of your current treatment before approving any change, that's a clinical safeguard, not a hoop to jump through.

If the specific dose you need is temporarily out of stock, our prescribers can advise you on timing or whether an alternative step makes clinical sense. Think of it like a pen in the fridge door: you'd notice immediately if it was gone, but you'd want your prescriber to weigh in before switching what replaces it. We dispense Mounjaro in all licensed UK strengths (2.5 mg through to 15 mg) and availability information for each dose is on our individual strength pages. If you're curious which dose you'd be likely to start on, our Mounjaro treatment page covers the licensed schedule in full.

Eligibility, the clinical picture, briefly

Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related health condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds can apply depending on ethnic background under UK clinical guidance. A BMI figure alone never determines approval; the prescriber reviews the whole clinical picture, including your medical history and any medicines you already take.

For people wondering about NHS access, NICE recommended tirzepatide for a phased NHS rollout from June 2025, but criteria are strict, waiting lists exist, and the rollout is gradual. Our page on Mounjaro's NHS timeline explains the current cohort thresholds clearly. Private treatment through a regulated pharmacy is the route for people who don't yet qualify or prefer not to wait. There's no referral needed and no waiting list, just a clinical assessment to confirm suitability. See an overview of all weight-loss treatment options if you'd like to compare before deciding.